A detailed history of Biechele Royce Advisors transactions in Cvs Health Corp stock. As of the latest transaction made, Biechele Royce Advisors holds 202,800 shares of CVS stock, worth $12 Million. This represents 5.36% of its overall portfolio holdings.

Number of Shares
202,800
Previous 199,287 1.76%
Holding current value
$12 Million
Previous $15.7 Million 2.8%
% of portfolio
5.36%
Previous 5.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$71.99 - $81.42 $252,900 - $286,028
3,513 Added 1.76%
202,800 $16.2 Million
Q4 2023

Feb 13, 2024

BUY
$66.29 - $79.0 $465,223 - $554,422
7,018 Added 3.65%
199,287 $15.7 Million
Q3 2023

Nov 01, 2023

BUY
$65.17 - $76.41 $406,139 - $476,187
6,232 Added 3.35%
192,269 $13.4 Million
Q2 2023

Aug 08, 2023

BUY
$66.65 - $77.75 $1.7 Million - $1.98 Million
25,508 Added 15.89%
186,037 $12.9 Million
Q1 2023

May 10, 2023

BUY
$72.37 - $92.89 $858,597 - $1.1 Million
11,864 Added 7.98%
160,529 $11.9 Million
Q4 2022

Feb 13, 2023

BUY
$88.25 - $103.78 $103,076 - $121,215
1,168 Added 0.79%
148,665 $13.9 Million
Q3 2022

Nov 10, 2022

SELL
$92.53 - $106.43 $130,004 - $149,534
-1,405 Reduced 0.94%
147,497 $14.1 Million
Q2 2022

Aug 03, 2022

SELL
$88.66 - $106.64 $27,395 - $32,951
-309 Reduced 0.21%
148,902 $13.8 Million
Q1 2022

May 10, 2022

SELL
$100.77 - $110.83 $297,876 - $327,613
-2,956 Reduced 1.94%
149,211 $15.1 Million
Q4 2021

Feb 09, 2022

BUY
$83.15 - $103.7 $65,605 - $81,819
789 Added 0.52%
152,167 $15.7 Million
Q3 2021

Nov 12, 2021

BUY
$80.05 - $87.47 $833,640 - $910,912
10,414 Added 7.39%
151,378 $12.8 Million
Q2 2021

Jul 14, 2021

BUY
$73.79 - $89.81 $567,666 - $690,908
7,693 Added 5.77%
140,964 $11.8 Million
Q1 2021

May 12, 2021

BUY
$68.13 - $76.3 $137,418 - $153,897
2,017 Added 1.54%
133,271 $10 Million
Q4 2020

Feb 04, 2021

BUY
$55.93 - $74.5 $162,588 - $216,571
2,907 Added 2.26%
131,254 $8.97 Million
Q3 2020

Nov 03, 2020

SELL
$56.71 - $65.71 $221,169 - $256,268
-3,900 Reduced 2.95%
128,347 $7.5 Million
Q2 2020

Jul 30, 2020

SELL
$55.41 - $70.62 $80,067 - $102,045
-1,445 Reduced 1.08%
132,247 $8.59 Million
Q1 2020

Apr 23, 2020

SELL
$52.3 - $76.05 $59,465 - $86,468
-1,137 Reduced 0.84%
133,692 $7.93 Million
Q4 2019

Jan 31, 2020

SELL
$60.38 - $76.58 $213,322 - $270,557
-3,533 Reduced 2.55%
134,829 $10 Million
Q3 2019

Oct 18, 2019

SELL
$54.09 - $64.3 $590,879 - $702,413
-10,924 Reduced 7.32%
138,362 $8.73 Million
Q2 2019

Jul 16, 2019

BUY
$52.13 - $57.33 $1.69 Million - $1.86 Million
32,379 Added 27.7%
149,286 $8.14 Million
Q1 2019

Apr 17, 2019

BUY
$52.36 - $69.88 $341,387 - $455,617
6,520 Added 5.91%
116,907 $6.31 Million
Q4 2018

Feb 05, 2019

BUY
$62.92 - $80.8 $211,725 - $271,892
3,365 Added 3.14%
110,387 $7.23 Million
Q3 2018

Oct 30, 2018

SELL
$63.78 - $79.59 $15,881 - $19,817
-249 Reduced 0.23%
107,022 $8.43 Million
Q2 2018

Jul 20, 2018

BUY
$60.71 - $72.18 $1.05 Million - $1.25 Million
17,362 Added 19.31%
107,271 $6.9 Million
Q1 2018

Apr 20, 2018

BUY
$60.6 - $83.63 $236,521 - $326,407
3,903 Added 4.54%
89,909 $5.59 Million
Q4 2017

Feb 08, 2018

BUY
$66.8 - $80.91 $5.75 Million - $6.96 Million
86,006
86,006 $6.24 Million

Others Institutions Holding CVS

About CVS HEALTH Corp


  • Ticker CVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 1,312,829,952
  • Market Cap $77.5B
  • Description
  • CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...
More about CVS
Track This Portfolio

Track Biechele Royce Advisors Portfolio

Follow Biechele Royce Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biechele Royce Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Biechele Royce Advisors with notifications on news.